Manning & Napier Group's ABT Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 155 shares of Abbott Laboratories (ABT) worth $20,761, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Manning & Napier Group has maintained a long-term strategic position in ABT, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2016, adding 130,768 shares. Largest reduction occurred in Q3 2025, reducing 271,875 shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Abbott Laboratories (ABT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Abbott Laboratories (ABT) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +35,656 | Add 0.00% | 35,655 | $34.86 |
| Q3 2013 | -14,202 | Reduce 39.83% | 21,453 | $33.19 |
| Q4 2013 | -21,453 | Sold Out | 21,453 | $33.19 |
| Q2 2016 | +152,221 | New Buy | 152,221 | $39.30 |
| Q3 2016 | -2,858 | Reduce 1.88% | 149,363 | $42.29 |
| Q4 2016 | +4,909 | Add 3.29% | 154,272 | $38.41 |
| Q1 2017 | +40,598 | Add 26.32% | 194,870 | $44.40 |
| Q2 2017 | -194,870 | Sold Out | 194,870 | $44.40 |
| Q2 2022 | +277,110 | New Buy | 277,110 | $108.65 |
| Q3 2022 | -3,571 | Reduce 1.29% | 273,539 | $96.75 |
| Q4 2022 | +5,212 | Add 1.91% | 278,751 | $109.79 |
| Q1 2023 | -1,258 | Reduce 0.45% | 277,493 | $101.26 |
| Q2 2023 | +72,070 | Add 25.97% | 349,563 | $109.02 |
| Q3 2023 | -2,647 | Reduce 0.76% | 346,916 | $96.85 |
| Q4 2023 | -47,951 | Reduce 13.82% | 298,965 | $110.07 |
| Q1 2024 | -26,935 | Reduce 9.01% | 272,030 | $113.66 |
| Q3 2025 | +155 | New Buy | 155 | $133.94 |
Manning & Napier Group's Abbott Laboratories Investment FAQs
Manning & Napier Group first purchased Abbott Laboratories (ABT) in Q2 2013, acquiring 35,655 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Abbott Laboratories (ABT) for 50 quarters since Q2 2013.
Manning & Napier Group's largest addition to Abbott Laboratories (ABT) was in Q2 2022, adding 277,110 shares worth $30.11 M.
According to the latest 13F filing for Q3 2025, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 155 shares of Abbott Laboratories (ABT), valued at approximately $20,761.
As of the Q3 2025 filing, Abbott Laboratories (ABT) represents approximately 0.00% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in Abbott Laboratories (ABT) was 349,563 shares, as reported at the end of Q2 2023.